Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04537715
Title Study to Describe the Interaction Between Tazemetostat and Itraconazole and Between Tazemetostat and Rifampin in Participants With Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Epizyme, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
California Cancer Associates for Research and Excellence, Inc. (cCARE) Encinitas California 92024 United States Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
Northwestern University-Robert H. Lurie Comprehensive Cancer Center Chicago Illinois 60611 United States Details
South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids Michigan 49546 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45267 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
Onkologikoa Donostia Gipuzkoa 20014 Spain Details
Hospital Universitario Vall d'Hebron Barcelona 08035 Spain Details
Hospital Fundacion Jimenez Diaz Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field